New advances in musculoskeletal pain

Brain Research Reviews

Volumn 60, Issue 1, 2009, Pages 187-201

  Bove, Susan E ^a   Flatters, Sarah J L ^b   Inglis, Julia J ^c   Mantyh, Patrick W ^d,e  

^a PFIZER INC   (United States)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^e VA MEDICAL CENTER   (United States)

Author keywords

Bone healing; Fracture; Osteoarthritis; Osteoporosis; Post surgical pain

Indexed keywords

2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; ANALGESIC AGENT; CYCLOOXYGENASE 2 INHIBITOR; GABAPENTIN; MORPHINE SULFATE; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; NERVE GROWTH FACTOR ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL;

AGITATION; BALANCE IMPAIRMENT; BONE PAIN; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; COGNITIVE DEFECT; CONSTIPATION; DISEASE MODEL; DIZZINESS; DRUG DEPENDENCE; FRACTURE; HUMAN; LOW BACK PAIN; MUSCULOSKELETAL PAIN; NONHUMAN; OSTEOARTHRITIS; OSTEOPOROSIS; PAIN; POSTOPERATIVE PAIN; PRIORITY JOURNAL; REFERRED PAIN; REVIEW; RHEUMATOID ARTHRITIS; SIDE EFFECT; SOMNOLENCE; STOMACH ULCER;

ANIMALS; ARTHRALGIA; BONE AND BONES; DISEASE MODELS, ANIMAL; FRACTURES, BONE; HUMANS; HYPERALGESIA; INFLAMMATION; MICE; MUSCULOSKELETAL DISEASES; OSTEOARTHRITIS; PAIN, POSTOPERATIVE; RATS; THORACOTOMY;

EID: 63749092528     PISSN: 01650173     EISSN: 18726321     Source Type: Journal    
DOI: 10.1016/j.brainresrev.2008.12.012     Document Type: Review

References (130)

1. Artico M., Bosco S., Cavallotti C., Agostinelli E., Giuliani-Piccari G., Sciorio S., Cocco L., and Vitale M. Noradrenergic and cholinergic innervation of the bone marrow. Int. J. Mol. Med. 10 1 (2002) 77-80
2. Aspenberg P. Avoid cox inhibitors after skeletal surgery!. Acta Orthop. Scand. 73 5 (2002) 489-490
3. Averbeck B., Rudolphi K., and Michaelis M. Osteoarthritic mice exhibit enhanced prostaglandin E2 and unchanged calcitonin gene-related peptide release in a novel isolated knee joint model. J. Rheumatol. 31 10 (2004) 2013-2020
4. Bajaj P., Bajaj P., Graven-Nielsen T., and Arendt-Nielsen L. Osteoarthritis and its association with muscle hyperalgesia: an experimental controlled study. Pain 93 2 (2001) 107-114
5. Balano K.B. Anti-inflammatory drugs and myorelaxants. Pharmacology and clinical use in musculoskeletal disease. Prim. Care 23 2 (1996) 329-334
6. Barve R.A., Minnerly J.C., Weiss D.J., Meyer D.M., Aguiar D.J., Sullivan P.M., Weinrich S.L., and Head R.D. Transcriptional profiling and pathway analysis of monosodium iodoacetate-induced experimental osteoarthritis in rats: relevance to human disease. Osteoarthr. Cartil. 15 10 (2007) 1190-1198
7. Bendele A.M. Animal models of osteoarthritis. J. Musculoskelet. Neuronal Interact. 1 4 (2001) 363-376
8. Bennett D.L., Koltzenburg M., Priestley J.V., Shelton D.L., and McMahon S.B. Endogenous nerve growth factor regulates the sensitivity of nociceptors in the adult rat. Eur. J. Neurosci. 10 4 (1998) 1282-1291
9. Beyreuther B., Callizot N., and Stohr T. Antinociceptive efficacy of lacosamide in the monosodium iodoacetate rat model for osteoarthritis pain. Arthritis Res. Ther. 9 1 (2007) R14
10. Bhattacharyya T., Levin R., Vrahas M.S., and Solomon D.H. Nonsteroidal antiinflammatory drugs and nonunion of humeral shaft fractures. Arthritis Rheum. 53 3 (2005) 364-367
11. Bielefeldt K., Ozaki N., and Gebhart G.F. Role of nerve growth factor in modulation of gastric afferent neurons in the rat. Am. J. Physiol. Gastrointest. Liver Physiol. 284 3 (2003) G499-G507
12. Bjurholm A., Kreicbergs A., Brodin E., and Schultzberg M. Substance P- and CGRP-immunoreactive nerves in bone. Peptides 9 1 (1988) 165-171
13. Blasier R.D. Treatment of fractures complicated by burn or head injuries in children. Instr. Course Lect. 49 (2000) 425-430
14. Bone L.B., Johnson K.D., Weigelt J., and Scheinberg R. Early versus delayed stabilization of femoral fractures: a prospective randomized study. 1989. Clin. Orthop. Relat. Res. 422 (2004) 11-16
15. Bove S.E., Calcaterra S.L., Brooker R.M., Huber C.M., Guzman R.E., Juneau P.L., Schrier D.J., and Kilgore K.S. Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritis. Osteoarthr. Cartil. 11 11 (2003) 821-830
16. Bove S.E., Laemont K.D., Brooker R.M., Osborn M.N., Sanchez B.M., Guzman R.E., Hook K.E., Juneau P.L., Connor J.R., and Kilgore K.S. Surgically induced osteoarthritis in the rat results in the development of both osteoarthritis-like joint pain and secondary hyperalgesia. Osteoarthr. Cartil. 14 10 (2006) 1041-1048
17. Bradley L.A., Kersh B.C., DeBerry J.J., Deutsch G., Alarcon G.A., and McLain D.A. Lessons from fibromyalgia: abnormal pain sensitivity in knee osteoarthritis. Novartis Found. Symp. 260 (2004) 258-270 discussion 270-259
18. Brandt K.D. Animal models of osteoarthritis. Biorheology 39 1-2 (2002) 221-235
19. Brennan T.J., Vandermeulen E.P., and Gebhart G.F. Characterization of a rat model of incisional pain. Pain 64 3 (1996) 493-501
20. Brumback R.J., Toal Jr. T.R., Murphy-Zane M.S., Novak V.P., and Belkoff S.M. Immediate weight-bearing after treatment of a comminuted fracture of the femoral shaft with a statically locked intramedullary nail. J. Bone Joint Surg. Am. 81 11 (1999) 1538-1544
21. Brunton S., Carmichael B., Gold D., Hull B., Kauffman T., Papaioannou A., Rasch R., Stracke H.H., and Truumees E. Vertebral compression fractures in primary care: recommendations from a consensus panel. J. Fam. Pract. 54 9 (2005) 781-788
22. Buvanendran A., Kroin J.S., Kerns J.M., Nagalla S.N., and Tuman K.J. Characterization of a new animal model for evaluation of persistent postthoracotomy pain. Anesth. Analg. 99 5 (2004) 1453-1460
23. Camuso M.R. Far-forward fracture stabilization: external fixation versus splinting. J. Am. Acad. Orthop. Surg. 14 Suppl. 10 (2006) S118-123
24. Center J.R., Nguyen T.V., Schneider D., Sambrook P.N., and Eisman J.A. Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet 353 9156 (1999) 878-882
25. Chhabra A., Zijerdi D., Zhang J., Kline A., Balian G., and Hurwitz S. BMP-14 deficiency inhibits long bone fracture healing: a biochemical, histologic, and radiographic assessment. J. Orthop. Trauma 19 9 (2005) 629-634
26. chLeonelli S.M., Goldberg B.A., Safanda J., Bagwe M.R., Sethuratnam S., and King S.J. Effects of a cyclooxygenase-2 inhibitor (rofecoxib) on bone healing. Am. J. Orthop. 35 2 (2006) 79-84
27. Clements K.M., Price J.S., Chambers M.G., Visco D.M., Poole A.R., and Mason R.M. Gene deletion of either interleukin-1beta, interleukin-1beta-converting enzyme, inducible nitric oxide synthase, or stromelysin 1 accelerates the development of knee osteoarthritis in mice after surgical transection of the medial collateral ligament and partial medial meniscectomy. Arthritis Rheum. 48 12 (2003) 3452-3463
28. Combe R., Bramwell S., and Field M.J. The monosodium iodoacetate model of osteoarthritis: a model of chronic nociceptive pain in rats?. Neurosci. Lett. 370 2-3 (2004) 236-240
29. Cooper C., Campion G., and Melton III L.J. Hip fractures in the elderly: a world-wide projection. Osteoporos. Int. 2 6 (1992) 285-289
30. Court-Brown C.M., and Koval K.J. The epidemiology of fractures. In: Bucholz R.W., Heckman J.D., and Court-Brown C.M. (Eds). Rockwood and Green's Fractures in Adults Vol. 1 (2006), Lippincott Williams&Wilkins, Philadelphia 95-144
31. Crandall M., Miaskowski C., Kools S., and Savedra M. The pain experience of adolescents after acute blunt traumatic injury. Pain Manag. Nurs. 3 3 (2002) 104-114
32. de Mos M., de Bruijn A.G., Huygen F.J., Dieleman J.P., Stricker B.H., and Sturkenboom M.C. The incidence of complex regional pain syndrome: a population-based study. Pain 129 1-2 (2006) 12-20
33. Delafoy L., Raymond F., Doherty A.M., Eschalier A., and Diop L. Role of nerve growth factor in the trinitrobenzene sulfonic acid-induced colonic hypersensitivity. Pain 105 3 (2003) 489-497
34. Dennison E., Mohamed M.A., and Cooper C. Epidemiology of osteoporosis. Rheum. Dis. Clin. North Am. 32 4 (2006) 617-629
35. Dmitrieva N., and McMahon S.B. Sensitisation of visceral afferents by nerve growth factor in the adult rat. Pain 66 1 (1996) 87-97
36. Duarte A.M., Pospisilova E., Reilly E., Mujenda F., Hamaya Y., and Strichartz G.R. Reduction of postincisional allodynia by subcutaneous bupivacaine: findings with a new model in the hairy skin of the rat. Anesthesiology 103 1 (2005) 113-125
37. Ekman E.F., and Koman L.A. Acute pain following musculoskeletal injuries and orthopaedic surgery: mechanisms and management. Instr. Course Lect. 54 (2005) 21-33
38. Ekstrom H., and Elmstahl S. Pain and fractures are independently related to lower walking speed and grip strength: results from the population study "Good Ageing in Skane". Acta Orthop. 77 6 (2006) 902-911
39. Emami A., Larsson S., Hellquist E., and Mallmin H. Limited bone loss in the hip and heel after reamed intramedullary fixation and early weight-bearing of tibial fractures. J. Orthop. Trauma 15 8 (2001) 560-565
40. Ensrud K.E., Blackwell T., Mangione C.M., Bowman P.J., Bauer D.C., Schwartz A., Hanlon J.T., Nevitt M.C., and Whooley M.A. Central nervous system active medications and risk for fractures in older women. Arch. Intern. Med. 163 8 (2003) 949-957
41. Feinberg S.D., 2000. Prescribing analgesics. How to improve function and avoid toxicity when treating chronic pain. Geriatrics;55(11), 44, 49-50, 53 passim.
42. Fernihough J., Gentry C., Malcangio M., Fox A., Rediske J., Pellas T., Kidd B., Bevan S., and Winter J. Pain related behaviour in two models of osteoarthritis in the rat knee. Pain 112 1-2 (2004) 83-93
43. Fernihough J., Gentry C., Bevan S., and Winter J. Regulation of calcitonin gene-related peptide and TRPV1 in a rat model of osteoarthritis. Neurosci. Lett. 388 2 (2005) 75-80
44. Feuerstein M., Berkowitz S.M., and Peck Jr. C.A. Musculoskeletal-related disability in US Army personnel: prevalence, gender, and military occupational specialties. J. Occup. Environ. Med. 39 1 (1997) 68-78
45. Flatters S.J.L. Characterization of a model of persistent postoperative pain evoked by skin/muscle incision and retraction (SMIR). Pain 135 1-2 (2008) 119-130
46. Freeman K.T., Koewler N.J., Jimenez-Andrade J.M., Buus R.J., Herrera M.B., Martin C.D., Ghilardi J.R., Kuskowski M.A., and Mantyh P.W. A fracture pain model in the rat: adaptation of a closed femur fracture model to study skeletal pain. Anesthesiology 108 3 (2008) 473-483
47. Gardner M.J., van der Meulen M.C., Demetrakopoulos D., Wright T.M., Myers E.R., and Bostrom M.P. In vivo cyclic axial compression affects bone healing in the mouse tibia. J. Orthop. Res. 24 8 (2006) 1679-1686
48. Gerstenfeld L.C., Thiede M., Seibert K., Mielke C., Phippard D., Svagr B., Cullinane D., and Einhorn T.A. Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs. J. Orthop. Res. 21 4 (2003) 670-675
49. Giannoudis P.V., MacDonald D.A., Matthews S.J., Smith R.M., Furlong A.J., and De Boer P. Nonunion of the femoral diaphysis. The influence of reaming and non-steroidal anti-inflammatory drugs. J. Bone Joint Surg., Br. 82 5 (2000) 655-658
50. Glasson S.S., Askew R., Sheppard B., Carito B.A., Blanchet T., Ma H.L., Flannery C.R., Kanki K., Wang E., Peluso D., Yang Z., Majumdar M.K., and Morris E.A. Characterization of and osteoarthritis susceptibility in ADAMTS-4-knockout mice. Arthritis Rheum. 50 8 (2004) 2547-2558
51. Glasson S.S., Askew R., Sheppard B., Carito B., Blanchet T., Ma H.L., Flannery C.R., Peluso D., Kanki K., Yang Z., Majumdar M.K., and Morris E.A. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature 434 7033 (2005) 644-648
52. Gould III H.J., Gould T.N., England J.D., Paul D., Liu Z.P., and Levinson S.R. A possible role for nerve growth factor in the augmentation of sodium channels in models of chronic pain. Brain Res. 854 1-2 (2000) 19-29
53. Greenfield G.Q. Orthopaedic pain. In: Boswell M.V., and Cole B.E. (Eds). Weiner's Pain Management: A Practical Guide for Clinicians Vol. 1 (2006), CRC Press, Boca Raton 465-476
54. Grills B.L., and Schuijers J.A. Immunohistochemical localization of nerve growth factor in fractured and unfractured rat bone. Acta Orthop. Scand. 69 4 (1998) 415-419
55. Guzman R.E., Evans M.G., Bove S., Morenko B., and Kilgore K. Mono-iodoacetate-induced histologic changes in subchondral bone and articular cartilage of rat femorotibial joints: an animal model of osteoarthritis. Toxicol. Pathol. 31 6 (2003) 619-624
56. Haegerstam G.A. Pathophysiology of bone pain: a review. Acta Orthop. Scand. 72 3 (2001) 308-317
57. Hame S.L., LaFemina J.M., McAllister D.R., Schaadt G.W., and Dorey F.J. Fractures in the collegiate athlete. Am. J. Sports Med. 32 2 (2004) 446-451
58. Hedequist D., Starr A.J., Wilson P., and Walker J. Early versus delayed stabilization of pediatric femur fractures: analysis of 387 patients. J. Orthop. Trauma 13 7 (1999) 490-493
59. Hefti F.F., Rosenthal A., Walicke P.A., Wyatt S., Vergara G., Shelton D.L., and Davies A.M. Novel class of pain drugs based on antagonism of NGF. Trends Pharmacol. Sci. 27 2 (2006) 85-91
60. Helminen H.J., Saamanen A.M., Salminen H., and Hyttinen M.M. Transgenic mouse models for studying the role of cartilage macromolecules in osteoarthritis. Rheumatology (Oxford) 41 8 (2002) 848-856
61. Hill E.L., and Elde R. Calcitonin gene-related peptide-immunoreactive nerve fibers in mandibular periosteum of rat: evidence for primary afferent origin. Neurosci. Lett. 85 2 (1988) 172-178
62. Hill E.L., and Elde R. Distribution of CGRP-, VIP-, DβH-, SP-, and NPY-immunoreactive nerves in the periosteum of the rat. Cell Tissue Res. 264 (1991) 469-480
63. Hukkanen M., Konttinen Y.T., Santavirta S., Paavolainen P., Gu X.H., Terenghi G., and Polak J.M. Rapid proliferation of calcitonin gene-related peptide-immunoreactive nerves during healing of rat tibial fracture suggests neural involvement in bone growth and remodelling. Neuroscience 54 4 (1993) 969-979
64. Inglis J.J., McNamme K.E., Chia S.L., Essex D., M.F., Williams R.O., Hunt S.P., and Vincent T. Pain sensitivity in osteoarthritis is regulated by the endogenous peripheral opioid system. Arthritis Rheum. 10 4 (2008) 3110-3119
65. Inman V.T., and Saunders J.B. Referred pain from skeletal structures. J. Nerve Ment. Dis. 99 (1944) 660-667
66. Ivanavicius S.P., Ball A.D., Heapy C.G., Westwood F.R., Murray F., and Read S.J. Structural pathology in a rodent model of osteoarthritis is associated with neuropathic pain: increased expression of ATF-3 and pharmacological characterisation. Pain 128 3 (2007) 272-282
67. Ji R.R., Samad T.A., Jin S.X., Schmoll R., and Woolf C.J. p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron 36 1 (2002) 57-68
68. Jimenez-Andrade J.M., Martin C.D., Koewler N.J., Freeman K.T., Sullivan L.J., Halvorson K.G., Barthold C.M., Peters C.M., Buus R.J., Ghilardi J.R., Lewis J.L., Kuskowski M.A., and Mantyh P.W. Nerve growth factor sequestering therapy attenuates non-malignant skeletal pain following fracture. Pain 133 1-3 (2007) 183-196
69. Jimenez-Andrade J.M., Herrera M.B., Ghilardi J.R., Vardanyan M., Melemedjian O.K., and Mantyh P.W. Vascularization of the dorsal root ganglia and peripheral nerve of the mouse: implications for chemical-induced peripheral sensory neuropathies. Mol. Pain 4 1 (2008) 10
70. Johnell O., and Kanis J. Epidemiology of osteoporotic fractures. Osteoporos. Int. 16 Suppl. 2 (2005) S3-S7
71. Johnell O., and Kanis J.A. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos. Int. 17 12 (2006) 1726-1733
72. Kehlet H., Jensen T.S., and Woolf C.J. Persistent postsurgical pain: risk factors and prevention. Lancet 367 9522 (2006) 1618-1625
73. Kenwright J., and Gardner T. Mechanical influences on tibial fracture healing. Clin. Orthop. Relat. Res. Suppl 355 (1998) S179-S190
74. Kerr B.J., Souslova V., McMahon S.B., and Wood J.N. A role for the TTX-resistant sodium channel Nav 1.8 in NGF-induced hyperalgesia, but not neuropathic pain. Neuroreport 12 14 (2001) 3077-3080
75. Kidd B.L. Osteoarthritis and joint pain. Pain 123 1-2 (2006) 6-9
76. King T., Vardanyan A., Majuta L., Melemedjian O., Nagle R., Cress A.E., Vanderah T.W., Lai J., and Porreca F. Morphine treatment accelerates sarcoma-induced bone pain, bone loss, and spontaneous fracture in a murine model of bone cancer. Pain 132 1-2 (2007) 154-168
77. Koester M.C., and Spindler K.P. Pharmacologic agents in fracture healing. Clin. Sports Med. 25 1 (2006) 63-73
78. Koewler N.J., Freeman K.T., Buus R.J., Herrera M.B., Jimenez-Andrade J.M., Ghilardi J.R., Peters C.M., Sullivan L.J., Kuskowski M.A., Lewis J.L., and Mantyh P.W. Effects of a monoclonal antibody raised against nerve growth factor on skeletal pain and bone healing following fracture of the C57BL/6J mouse femur. J. Bone Miner Res. 22 11 (2007) 1732-1742
79. Koval K.J., and Cooley M. The epidemiology of fractures: experience in the United States. In: Bucholz R.W., Heckman J.D., and Court-Brown C. (Eds). Rockwood and Green's Fractures in Adults Vol. 2 (2006), Lippincott Williams&Wilkins, Philadelphia 123-143
80. Koval K.J., Sala D.A., Kummer F.J., and Zuckerman J.D. Postoperative weight-bearing after a fracture of the femoral neck or an intertrochanteric fracture. J. Bone Joint Surg. Am. 80 3 (1998) 352-356
81. Lang T.F. What do we know about fracture risk in long-duration spaceflight?. J. Musculoskelet. Neuronal Interact. 6 4 (2006) 319-321
82. Levine J.D., Fields H.L., and Basbaum A.I. Peptides and the primary afferent nociceptor. J. Neurosci. 13 6 (1993) 2273-2286
83. Lewin G.R., Ritter A.M., and Mendell L.M. Nerve growth factor-induced hyperalgesia in the neonatal and adult rat. J. Neurosci. 13 5 (1993) 2136-2148
84. Lewin G.R., Rueff A., and Mendell L.M. Peripheral and central mechanisms of NGF-induced hyperalgesia. Eur. J. Neurosci. 6 (1994) 1903-1912
85. Mach D.B., Rogers S.D., Sabino M.C., Luger N.M., Schwei M.J., Pomonis J.D., Keyser C.P., Clohisy D.R., Adams D.J., O'Leary P., and Mantyh P.W. Origins of skeletal pain: sensory and sympathetic innervation of the mouse femur. Neuroscience 113 1 (2002) 155-166
86. Mahowald M.L., Singh J.A., and Majeski P. Opioid use by patients in an orthopedics spine clinic. Arthritis Rheum. 52 1 (2005) 312-321
87. Malik-Hall M., Dina O.A., and Levine J.D. Primary afferent nociceptor mechanisms mediating NGF-induced mechanical hyperalgesia. Eur. J. Neurosci. 21 12 (2005) 3387-3394
88. Mamaril M.E., Childs S.G., and Sortman S. Care of the orthopaedic trauma patient. J. Perianesth. Nurs. 22 3 (2007) 184-194
89. Mason L., Moore R.A., Edwards J.E., Derry S., and McQuay H.J. Topical NSAIDs for chronic musculoskeletal pain: systematic review and meta-analysis. BMC Musculoskelet. Disord. 5 (2004) 28
90. Massey G.M., Dodds H.N., Roberts C.S., Servoss T.J., and Blondell R.D. Toxicology screening in orthopedic trauma patients predicting duration of prescription opioid use. J. Addict. Dis. 24 4 (2005) 31-41
91. Mazess R.B. On aging bone loss. Clin. Orthop. Relat. Res. 165 (1982) 239-252
92. McCann H.L., and Stanitski D.F. Pediatric orthopaedic surgery pain management. J. Pediatr. Orthop. 24 5 (2004) 581-586
93. McDougall J.J. Arthritis and pain. Neurogenic origin of joint pain. Arthritis Res. Ther. 8 6 (2006) 220
94. McMahon S.B., Bennett D.L.H., and Bevan S. Inflammatory mediators and modulators of pain. In: McMahon S.B., and Koltzenburg M. (Eds). Textbook of Pain Vol. 1 (2006), Elsevier Churchill Livingstone, London 49-72
95. McSwain Jr. N.E. Blunt and penetrating chest injuries. World J. Surg. 16 5 (1992) 924-929
96. Moholkar, K., Ziran, B., 2006. Local complications. In: Rockwood, C.A., Green, D.P., Bucholz, R.W. (Eds.), Rockwood and Green's Fractures in adults, Vol. 1. Lippincott Williams & Wilkins, Philadelphia, pp. 563-612.
97. Morenko B.J., Bove S.E., Chen L., Guzman R.E., Juneau P., Bocan T.M., Peter G.K., Arora R., and Kilgore K.S. In vivo micro computed tomography of subchondral bone in the rat after intra-articular administration of monosodium iodoacetate. Contemp. Top Lab. Anim. Sci. 43 1 (2004) 39-43
98. Murnaghan M., Li G., and Marsh D.R. Nonsteroidal anti-inflammatory drug-induced fracture nonunion: an inhibition of angiogenesis?. J. Bone Joint Surg., Am. 88 Suppl. 3 (2006) 140-147
99. Newton-John H.F., and Morgan D.B. The loss of bone with age, osteoporosis, and fractures. Clin. Orthop. Relat. Res. 71 (1970) 229-252
100. Nilsson B.E., and Edwards P. Age and fracture healing: a statistical analysis of 418 cases of tibial shaft fractures. Geriatrics 24 2 (1969) 112-117
101. Orsini L.S., Rousculp M.D., Long S.R., and Wang S. Health care utilization and expenditures in the United States: a study of osteoporosis-related fractures. Osteoporos. Int. 16 4 (2005) 359-371
102. Owens B.D., Kragh Jr. J.F., Macaitis J., Svoboda S.J., and Wenke J.C. Characterization of extremity wounds in Operation Iraqi Freedom and Operation Enduring Freedom. J. Orthop. Trauma 21 4 (2007) 254-257
103. Owings M.F., and Kozak L.J. Ambulatory and inpatient procedures in the United States, 1996. Vital Health Stat. 13 139 (1998) 1-119
104. Ozawa T., Aoki Y., Ohtori S., Takahashi K., Chiba T., Ino H., and Moriya H. The dorsal portion of the lumbar intervertebral disc is innervated primarily by small peptide-containing dorsal root ganglion neurons in rats. Neurosci. Lett. 344 1 (2003) 65-67
105. Ozawa T., Ohtori S., Inoue G., Aoki Y., Moriya H., and Takahashi K. The degenerated lumbar intervertebral disc is innervated primarily by peptide-containing sensory nerve fibers in humans. Spine 31 21 (2006) 2418-2422
106. Pape H.-C., and Giannoudis P. Management of the multiply injured patient. In: Rockwood C.A., Green D.P., and Bucholz R.W. (Eds). Rockwood and Green's Fractures in Adults Vol. 1 (2006), Lippincott Williams&Wilkins, Philadelphia 59-94
107. Payne M.W., Williams D.R., and Trudel G. Space flight rehabilitation. Am. J. Phys. Med. Rehabil. 86 7 (2007) 583-591
108. Petrizzi L., Mariscoli M., Valbonetti L., Varasano V., Langhoff J.D., and Von Rechenberg B. Preliminary study on the effect of parenteral naloxone, alone and in association with calcium gluconate, on bone healing in an ovine "drill hole" model system. BMC Musculoskelet. Disord. 8 (2007) 43
109. Pezet S., and McMahon S.B. Neurotrophins: mediators and modulators of pain. Annu. Rev. Neurosci. 29 (2006) 507-538
110. Pogatzki E.M., Niemeier J.S., and Brennan T.J. Persistent secondary hyperalgesia after gastrocnemius incision in the rat. Eur. J. Pain 6 4 (2002) 295-305
111. Pomonis J.D., Harrison J.E., Mark L., Bristol D.R., Valenzano K.J., and Walker K. N-(4-Tertiarybutylphenyl)-4-(3-cholorphyridin-2-yl)tetrahydropyrazine-1( 2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: II. in vivo characterization in rat models of inflammatory and neuropathic pain. J. Pharmacol. Exp. Ther. 306 1 (2003) 387-393
112. Pomonis J.D., Boulet J.M., Gottshall S.L., Phillips S., Sellers R., Bunton T., and Walker K. Development and pharmacological characterization of a rat model of osteoarthritis pain. Pain 114 3 (2005) 339-346
113. Poonawala T., Levay-Young B.K., Hebbel R.P., and Gupta K. Opioids heal ischemic wounds in the rat. Wound Repair Regen. 13 2 (2005) 165-174
114. Pritzker K.P. Animal models for osteoarthritis: processes, problems and prospects. Ann. Rheum. Dis. 53 6 (1994) 406-420
115. Sandroni P., Benrud-Larson L.M., McClelland R.L., and Low P.A. Complex regional pain syndrome type I: incidence and prevalence in Olmsted county, a population-based study. Pain 103 1-2 (2003) 199-207
116. Santy J., and Mackintosh C. A phenomenological study of pain following fractured shaft of femur. J. Clin. Nurs. 10 4 (2001) 521-527
117. Schuelert N., and McDougall J.J. Electrophysiological evidence that the vasoactive intestinal peptide receptor antagonist VIP6-28 reduces nociception in an animal model of osteoarthritis. Osteoarthr. Cartil. 14 11 (2006) 1155-1162
118. Schuelert N., and McDougall J.J. Cannabinoid-mediated antinociception is enhanced in rat osteoarthritic knees. Arthritis Rheum. 58 1 (2008) 145-153
119. Shu X., and Mendell L.M. Acute sensitization by NGF of the response of small-diameter sensory neurons to capsaicin. J. Neurophysiol. 86 6 (2001) 2931-2938
120. Simon A.M., and O'Connor J.P. Dose and time-dependent effects of cyclooxygenase-2 inhibition on fracture-healing. J. Bone Joint Surg., Am. 89 3 (2007) 500-511
121. Simon A.M., Manigrasso M.B., and O'Connor J.P. Cyclo-oxygenase 2 function is essential for bone fracture healing. J. Bone Miner. Res. 17 6 (2002) 963-976
122. The 2004 Surgeon General's Report on Bone Health and Osteoporosis: What It Means To You. Bone Health and Osteoporosis: The frecuency of bone diseases. U.S. Department of Health and Human Services, Office of the Surgeon General, 2004.
123. Varghese D., Kodakat S., and Patel H. Non-steroidal anti-inflammatories should not be used after orthopaedic surgery. BMJ 316 7141 (1998) 1390-1391
124. Vestergaard P., Rejnmark L., and Mosekilde L. Fracture risk associated with the use of morphine and opiates. J. Intern. Med. 260 1 (2006) 76-87
125. Walker W.C. Pain pathoetiology after TBI: neural and nonneural mechanisms. J. Head Trauma Rehabil. 19 1 (2004) 72-81
126. Wheeler P., and Batt M.E. Do non-steroidal anti-inflammatory drugs adversely affect stress fracture healing? A short review. Br. J. Sports Med. 39 2 (2005) 65-69
127. Yates D., and Smith M. Orthopaedic pain after trauma. In: Wall P.D., and Melzack R. (Eds). Textbook of Pain Vol. 1 (1994), Churchill Livingstone, New York 409-421
128. Zagon I.S., Sassani J.W., Myers R.L., and McLaughlin P.J. Naltrexone accelerates healing without compromise of adhesion complexes in normal and diabetic corneal epithelium. Brain Res. Bull. 72 1 (2007) 18-24
129. Zahn P.K., and Brennan T.J. Primary and secondary hyperalgesia in a rat model for human postoperative pain. Anesthesiology 90 3 (1999) 863-872
130. Zuckerman J.D., Zetterberg C., Kummer F.J., and Frankel V.H. Weightbearing following hip fractures in geriatric patients. Topics Geriatr. Rehabil. 6 (1990) 34-50